The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the c (Q54408278)
scientific article
Language:
Current Data About The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the c
(P31) (Q13442814)
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

(P304) 787-793
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

(P407) (Q1860)

(P433) 2
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

(P478) 144
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

(P577) Wednesday, April 1, 1987
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

(P921) (Q418817)
(P887)

(P1433) (Q864228)
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

(P1476) "The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the c" (language: en)
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

(P2093) E H Estey
(P1545) 1
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

L Silberman
(P1545) 2
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

M Beran
(P1545) 3
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

B S Andersson
(P1545) 4
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

L A Zwelling
(P1545) 5
(P248)
(P698) 3034264
(P813) Tuesday, May 29, 2018
(P854) http://europepmc.org/abstract/MED/3034264

(P2860) (Q41609915)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-291X%2887%2980033-5
(P813) Thursday, January 7, 2021

(Q54433856)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-291X%2887%2980033-5
(P813) Thursday, January 7, 2021

(Q70095180)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-291X%2887%2980033-5
(P813) Thursday, January 7, 2021

(Q70472093)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-291X%2887%2980033-5
(P813) Thursday, January 7, 2021

(Q54317128)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-291X%2887%2980033-5
(P813) Thursday, January 7, 2021

(Q70149955)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-291X%2887%2980033-5
(P813) Thursday, January 7, 2021

(Q64390440)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0006-291X%2887%2980033-5
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article

External Links
(P356) 10.1016/S0006-291X(87)80033-5
(P698) 3034264